TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 33 filers reported holding TRACON PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,953 | -38.8% | 84,003 | 0.0% | 0.01% | -25.0% |
| Q2 2023 | $24,445 | -84.6% | 84,003 | 0.0% | 0.01% | -84.6% |
| Q1 2023 | $158,766 | +126912.8% | 84,003 | 0.0% | 0.05% | +44.4% |
| Q4 2022 | $125 | -99.9% | 84,003 | 0.0% | 0.04% | -12.2% |
| Q3 2022 | $140,000 | -16.7% | 84,003 | 0.0% | 0.04% | -4.7% |
| Q2 2022 | $168,000 | -24.0% | 84,003 | 0.0% | 0.04% | +2.4% |
| Q1 2022 | $221,000 | -5.2% | 84,003 | 0.0% | 0.04% | +55.6% |
| Q4 2021 | $233,000 | -28.3% | 84,003 | 0.0% | 0.03% | -6.9% |
| Q3 2021 | $325,000 | – | 84,003 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,518,371 | $16,344,000 | 2.72% |
| Ikarian Capital, LLC | 2,716,840 | $17,631,000 | 1.42% |
| Telemetry Investments, L.L.C. | 40,000 | $260,000 | 0.36% |
| ACT CAPITAL MANAGEMENT, LLC | 28,500 | $185,000 | 0.10% |
| Vigilare Wealth Management | 17,000 | $110,000 | 0.07% |
| X-Square Capital, LLC | 20,973 | $136,000 | 0.06% |
| BOOTHBAY FUND MANAGEMENT, LLC | 294,031 | $1,908,000 | 0.06% |
| Johnson & Johnson Innovation - JJDC, Inc. | 84,003 | $545,000 | 0.06% |
| NEA Management Company, LLC | 346,718 | $2,250,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 36,370 | $236,000 | 0.03% |